[
  {
    "question": "How is HIV diagnosed?",
    "answer": "Okay, good question. HIV diagnosis generally follows a multi-step approach:\n\n1. **Initial Screening:** Usually an antibody test (blood, oral fluid, or rapid test). These detect antibodies the body makes against HIV.\n2. **Confirmation:** If the screening test is positive, a confirmatory test (like an HIV-1/HIV-2 antibody differentiation immunoassay) is done to confirm the result.\n3. **Viral Load Testing:** Measures the amount of HIV in the blood. Useful for recent infection, and to monitor treatment.\n4. **CD4 Count:** Measures the number of CD4 cells, which are immune cells affected by HIV. Helps assess immune system health.\n\nNewer tests combine antibody/antigen detection for earlier diagnosis. \n\nDoes that make sense? We can go into more detail on any step if you'd like.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "Okay, good question. HIV infection generally progresses through these stages:\n\n1. **Acute HIV Infection:** Initial infection, often with flu-like symptoms. High viral load.\n2. **Clinical Latency (Chronic HIV Infection):** Virus continues to multiply but at very low levels. People may be asymptomatic. This can last many years.\n3. **Acquired Immunodeficiency Syndrome (AIDS):** The most severe phase. Occurs when the immune system is severely damaged, leading to opportunistic infections and cancers.\n\nIt\u2019s important to remember that with treatment (antiretroviral therapy or ART), progression can be significantly slowed or halted.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "HIV is transmitted through specific bodily fluids:\n\n*   **Blood:** Sharing needles, accidental needle sticks.\n*   **Semen & Pre-seminal fluid:** Through sexual contact.\n*   **Vaginal fluids:** Through sexual contact.\n*   **Rectal fluids:** Through sexual contact.\n*   **Breast milk:** From mother to child during breastfeeding.\n\nIt is **not** spread through casual contact like air, saliva, sweat, tears, or insect bites.",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "Good question. People living with HIV (PLWH) can experience a higher prevalence of several comorbidities. Common ones include:\n\n*   **Cardiovascular disease:** Increased risk of heart attack, stroke, and heart failure.\n*   **Kidney disease:** HIV-associated nephropathy and accelerated progression of kidney dysfunction.\n*   **Liver disease:** Often related to hepatitis B or C co-infection, but also can be from other causes.\n*   **Neurological disorders:** Neurocognitive impairment, peripheral neuropathy.\n*   **Certain cancers:** Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer.\n*   **Mental health conditions:** Depression, anxiety.\n*   **Osteoporosis/Osteopenia:** Lower bone density.\n\n\n\nIt\u2019s important to remember that with effective antiretroviral therapy (ART) and improved overall health management, PLWH can live long and healthy lives, and the risk of many of these comorbidities is significantly reduced.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "Good question. HIV prevention strategies fall into a few key categories:\n\n1.  **Safe Sex:** Consistent and correct condom use.\n2.  **PrEP (Pre-Exposure Prophylaxis):** Daily medication for HIV-negative individuals at risk.\n3.  **PEP (Post-Exposure Prophylaxis):** Medication *after* a potential exposure.\n4.  **Treatment as Prevention (TasP):** People with HIV on effective treatment cannot sexually transmit the virus (Undetectable = Untransmittable or U=U).\n5.  **Harm Reduction:** Needle exchange programs for people who inject drugs.\n6.  **Prevention of Mother-to-Child Transmission:** Treatment during pregnancy, delivery, and breastfeeding.\n\n\n\nDo you want me to elaborate on any of these?",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "ART (antiretroviral therapy) needs to be taken **every day**, for life. Consistent, daily adherence is crucial for suppressing the virus, preventing drug resistance, and maintaining a healthy immune system. \n\nThere are some newer long-acting injectable options available now, but even those require regular injections to maintain therapeutic levels.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "Excellent question. Preventing perinatal HIV transmission is now highly effective with a multi-pronged approach:\n\n1. **Antiretroviral Therapy (ART):** This is the cornerstone. HIV-positive pregnant people should start and continue ART throughout pregnancy, labor, and delivery.\n2. **Scheduled Cesarean Delivery:** For those with high viral loads near delivery.\n3. **Infant Prophylaxis:** Newborns receive ART for a period after birth (typically 4-6 weeks).\n4. **Avoidance of Breastfeeding:** In resource-rich settings, formula feeding is recommended to eliminate transmission through breast milk.\n\nThese interventions have dramatically reduced transmission rates.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "HIV primarily infects these cells:\n\n*   **CD4+ T cells:** These are the main target and their depletion leads to immune deficiency.\n*   **Macrophages:** Act as a reservoir for the virus.\n*   **Dendritic cells:** Important in initial infection and transmission.\n\nThese cells express the CD4 receptor that HIV uses to enter.",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "That's a fundamental question. Here's the breakdown:\n\n**HIV (Human Immunodeficiency Virus)** is the virus itself. It attacks the immune system, specifically CD4 cells.\n\n**AIDS (Acquired Immunodeficiency Syndrome)** is the *late stage* of HIV infection. It develops when HIV has severely damaged the immune system, leaving the person vulnerable to opportunistic infections and certain cancers. \n\nEssentially, you *get* HIV, and if left untreated, HIV can *lead to* AIDS.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "That's a very important question to clarify! HIV is *not* transmitted through:\n\n*   Air or water\n*   Saliva, sweat, tears, or closed-mouth kissing\n*   Insects (like mosquitoes or ticks)\n*   Sharing toilets\n*   Casual contact (hugging, shaking hands)\n\n\n\nEssentially, it requires direct blood-to-blood contact, or specific sexual fluids. Focusing on *how* it isn't spread helps reduce stigma and anxiety.",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "That's a great question, and central to HIV cure research. Here's a breakdown of what we know about the switch from latency to active infection:\n\n**The Basics:** Latency means the virus is present in resting CD4+ T cells, but isn't actively replicating. It's essentially \"hidden\" from the immune system and most antiretroviral therapies. \n\n**What triggers activation?** A variety of stimuli can awaken the virus. These include:\n\n*   **Immune Activation:** From other infections, vaccinations, or even immune reconstitution after starting ART.\n*   **T Cell Activation:** Signals that normally activate T cells (e.g., from antigens) can also wake up latently infected cells.\n*   **Cytokines:** Inflammatory signals like IL-15 are important.\n*   **Epigenetic factors:** Changes in how DNA is packaged can influence latency.\n\n**The Process:** When a latent cell is activated, the integrated HIV provirus begins to be transcribed, producing viral RNA and proteins, ultimately leading to new virion production.\n\n**Key Challenges:** The biggest hurdle is that we don't fully understand *which* signals are most important in *whom*, and how to selectively activate the virus for elimination (the \"shock and kill\" strategy) without causing harmful inflammation.\n\n\n\nDoes that help as a starting point? We can delve into specific aspects if you like.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]